SYNH Syneos Health, Inc. Stock Quote

SYNH [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	38.91	EPS (ttm)	2.24	Insider Own	0.40%	Shs Outstand	103.94M	Perf Week	1.28%
Market Cap	9.11B	Forward P/E	17.36	EPS next Y	5.02	Insider Trans	-99.60%	Shs Float	61.25M	Perf Month	-7.66%
Income	235.90M	PEG	2.20	EPS next Q	1.17	Inst Own	87.13%	Short Float	3.52%	Perf Quarter	-0.99%
Sales	4.73B	P/S	1.93	EPS this Y	46.20%	Inst Trans	0.14%	Short Ratio	3.84	Perf Half Y	2.16%
Book/sh	31.16	P/B	2.80	EPS next Y	15.46%	ROA	3.00%	Target Price	100.40	Perf Year	43.39%
Cash/sh	2.50	P/C	34.88	EPS next 5Y	17.70%	ROE	7.40%	52W Range	51.04 - 97.47	Perf YTD	27.86%
Dividend	-	P/FCF	20.52	EPS past 5Y	-1.20%	ROI	4.60%	52W High	-10.63%	Beta	1.80
Dividend %	-	Quick Ratio	1.10	Sales past 5Y	25.80%	Gross Margin	23.80%	52W Low	70.67%	ATR	2.42
Employees	24310	Current Ratio	1.10	Sales Q/Q	26.60%	Oper. Margin	7.40%	RSI (14)	41.25	Volatility	1.73% 2.86%
Optionable	Yes	Debt/Eq	0.90	EPS Q/Q	973.50%	Profit Margin	5.00%	Rel Volume	0.53	Prev Close	87.71
Shortable	Yes	LT Debt/Eq	0.89	Earnings	Aug 09 BMO	Payout	0.00%	Avg Volume	561.90K	Price	87.11
Recom	1.80	SMA20	-3.03%	SMA50	-3.84%	SMA200	4.05%	Volume	295,472	Change	-0.68%

Aug-05-21

Resumed

Credit Suisse

Outperform

$96

Mar-03-21

Initiated

Barclays

Equal Weight

$84

Oct-06-20

Upgrade

Mizuho

Neutral → Buy

$65

Oct-01-20

Upgrade

Goldman

Neutral → Buy

$69 → $75

Mar-30-20

Downgrade

Goldman

Buy → Neutral

$79 → $45

Jan-07-20

Initiated

Citigroup

Buy

$75

Oct-19-18

Upgrade

William Blair

Mkt Perform → Outperform

Oct-09-18

Initiated

UBS

Buy

Oct-04-18

Initiated

Evercore ISI

Outperform

$58

Oct-18-21 12:53PM	Hedge Funds Are Crazy About Syneos Health, Inc. (SYNH Insider Monkey
Oct-13-21 09:30AM	Syneos Health's (SYNH) New Pact Boosts Tech-Driven Solutions Zacks
Oct-08-21 08:44AM	Syneos Health buys RTP data science firm in 'critical' move for CRO's future American City Business Journals
Oct-06-21 08:16AM	Syneos Health Acquires RxDataScience GlobeNewswire
Sep-29-21 10:41AM	Here's Why You Should Retain Syneos Health (SYNH) For Now Zacks
Sep-20-21 12:33PM	Is Syneos Health, Inc. (NASDAQ:SYNH) Potentially Undervalued? Simply Wall St.
08:31AM	NOVN: Syneos Selected as Commercialization Partner Zacks Small Cap Research
Sep-16-21 09:40AM	Syneos Health's (SYNH) New Buyout Boosts Clinical Solutions Arm Zacks
Sep-14-21 05:30PM	Syneos Health Acquires StudyKIK GlobeNewswire
Sep-10-21 10:00AM	Syneos Health (SYNH) Enhances Clinical Trials With New Pact Zacks
Sep-09-21 09:00AM	Syneos Health and Ride Health Partner to Improve Clinical Trial Recruitment and Retention GlobeNewswire
07:00AM	Novan Announces Strategic Priorities and Outlines Key Milestones GlobeNewswire
Sep-08-21 11:30AM	Syneos Health (SYNH) Up 11.8% Since Last Earnings Report: Can It Continue? Zacks
Aug-31-21 09:22AM	Syneos Health (SYNH) Hits a 52-Week High: What's Driving It? Zacks
Aug-30-21 09:00AM	Syneos Health to Present at the 2021 Baird Global Healthcare Conference GlobeNewswire
Aug-20-21 01:47PM	Investors in Syneos Health (NASDAQ:SYNH) have made a decent return of 100% over the past five years Simply Wall St.
Aug-10-21 09:56AM	Syneos Health (SYNH) Q2 Earnings Top Estimates, 2021 View Up Zacks
Aug-09-21 05:30PM	Syneos Health, inc (SYNH) Q2 2021 Earnings Call Transcript Motley Fool
07:35AM	Syneos Health (SYNH) Surpasses Q2 Earnings and Revenue Estimates Zacks
06:12AM	Syneos Health Reports Second Quarter 2021 Results GlobeNewswire
Aug-02-21 03:01PM	Syneos Health (SYNH) Earnings Expected to Grow: Should You Buy? Zacks
07:00AM	Syneos Health and Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization GlobeNewswire
Jul-21-21 06:35AM	Is Syneos Health, Inc.'s (NASDAQ:SYNH) Recent Stock Performance Influenced By Its Financials In Any Way? Simply Wall St.
Jul-14-21 08:00AM	Syneos Health Names Michael Brooks Chief Development Officer GlobeNewswire
Jul-12-21 04:05PM	Syneos Health Schedules Second Quarter 2021 Earnings Call for Monday, August 9, 2021 GlobeNewswire
03:39PM	Hedge Funds Are Selling Syneos Health, Inc. (SYNH) Insider Monkey
Jun-21-21 09:23AM	What Kind Of Shareholders Hold The Majority In Syneos Health, Inc.'s (NASDAQ:SYNH) Shares? Simply Wall St.
08:05AM	Syneos Health Accelerates Decentralized Clinical Trial Delivery, Unveils New Collaboration with Site Sponsors GlobeNewswire
Jun-08-21 07:40AM	Syneos' (SYNH) New Patient Consortium to Drive Innovation Zacks
Jun-03-21 10:00AM	Syneos Health Launches Patient Voice Consortium GlobeNewswire
05:19AM	Syneos Health Announces Pricing of Secondary Offering of Common Stock GlobeNewswire
Jun-02-21 04:01PM	Syneos Health Announces Secondary Offering of Common Stock GlobeNewswire
May-21-21 01:51PM	Syneos Health to Present at Upcoming Investor Conferences GlobeNewswire
05:56AM	Estimating The Intrinsic Value Of Syneos Health, Inc. (NASDAQ:SYNH) Simply Wall St.
May-14-21 08:13PM	Tellurian, Syneos Health See Activist Action Barrons.com
May-06-21 07:30AM	Syneos Health Leaders Recognized For Visionary Healthcare Expertise Through HBA GlobeNewswire
May-03-21 09:33PM	Syneos Health Announces Pricing of Secondary Offering of Common Stock GlobeNewswire
04:40PM	Syneos Health Announces Secondary Offering of Common Stock GlobeNewswire
07:00AM	Syneos Health Launches Lab to Life Enterprise Partnership with Komodo Health GlobeNewswire
May-01-21 10:30AM	Syneos Health, Inc. (SYNH) Q1 2021 Earnings Call Transcript Motley Fool
Apr-30-21 09:01AM	Syneos Health (SYNH) Q1 Earnings Top Estimates, Margins Up Zacks
05:05AM	Illingworth Research Group Recognized with Queens Award for Enterprise: International Trade 2021 GlobeNewswire
Apr-29-21 07:35AM	Syneos Health (SYNH) Tops Q1 Earnings and Revenue Estimates Zacks
06:16AM	Syneos Health Reports First Quarter 2021 Results GlobeNewswire
Apr-22-21 12:33PM	Syneos Health (SYNH) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Apr-20-21 09:00AM	Syneos Health Partners with Medable, Expanding Decentralized Solutions to Bring Clinical Trials Closer to the Patient GlobeNewswire
Apr-15-21 06:22AM	Here's Why I Think Syneos Health (NASDAQ:SYNH) Might Deserve Your Attention Today Simply Wall St. +7.86%
Apr-14-21 01:06PM	Is SYNH Stock A Buy or Sell? Insider Monkey
Apr-01-21 04:01PM	Syneos Health Schedules First Quarter 2021 Earnings Call for Thursday, April 29, 2021 GlobeNewswire
Mar-31-21 01:38PM	Reasons to Hold on to Syneos Health (SYNH) Stock For Now Zacks
Mar-30-21 11:44AM	Syneos Health (SYNH) New Partnership to Enhance Clinical Trials Zacks
Mar-29-21 07:00AM	Syneos Health Partners with Science 37® to Transform Clinical Trials Increasing Speed and Diversity GlobeNewswire
Mar-20-21 11:30AM	Why Is Syneos Health (SYNH) Up 4.1% Since Last Earnings Report? Zacks
Mar-16-21 07:18AM	What Does Syneos Health, Inc.'s (NASDAQ:SYNH) Share Price Indicate? Simply Wall St.
Mar-15-21 09:00AM	Syneos Health Communications Boosts Global Creative Capabilities with Renowned Talent GlobeNewswire
Mar-12-21 06:07PM	AnaptysBio and Seagate Technology See Activist Action Barrons.com
Mar-01-21 09:28AM	Syneos Health Announces Pricing of Secondary Offering of Common Stock GlobeNewswire
06:44AM	Syneos Health Announces Secondary Offering of Common Stock GlobeNewswire
Feb-24-21 09:00AM	Syneos Health and Protocol First Partner to Accelerate Collection and Review of Clinical Trial Data GlobeNewswire +5.06%
Feb-19-21 02:18PM	Price Over Earnings Overview: Syneos Health Benzinga
Feb-18-21 02:00PM	Syneos Health, Inc. (SYNH) Q4 2020 Earnings Call Transcript Motley Fool
07:54AM	Syneos Health: Q4 Earnings Insights Benzinga
06:53AM	Did You Miss Syneos Health's (NASDAQ:SYNH) Impressive 107% Share Price Gain? Simply Wall St.
06:15AM	Syneos Health Reports Fourth Quarter and Full Year 2020 Results GlobeNewswire
Feb-11-21 08:00AM	Syneos Health Identifies Important Drivers of Change Expected to Disrupt Healthcare GlobeNewswire
Jan-26-21 06:37PM	Syneos Health Schedules Fourth Quarter and Full Year 2020 Earnings Call for Thursday, February 18, 2021 GlobeNewswire
Jan-13-21 04:23AM	Have Insiders Been Buying Syneos Health, Inc. (NASDAQ:SYNH) Shares? Simply Wall St.
Jan-07-21 07:30AM	Why It Might Be Time To Pay Attention To These 3 Red-Hot Health Stocks Investor's Business Daily
07:15AM	Are These Medical Stocks Cruising Toward Bullish Gains? Here's A Key Sign Investor's Business Daily
Jan-04-21 04:15PM	Syneos Health to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-21-20 08:48AM	Syneos Health (SYNH) Buys Illingworth Research, Expands CRO Base Zacks
Dec-18-20 09:14AM	Syneos Health Acquires Illingworth Research Group, a Leading Provider of Clinical Research Home Health Services GlobeNewswire
04:00AM	Syneos Health, Inc.'s (NASDAQ:SYNH) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? Simply Wall St.
Dec-16-20 08:08AM	Syneos Health's (SYNH) Shares March Higher, Can It Continue? Zacks
Dec-15-20 10:28AM	Is SYNH A Good Stock To Buy Now? Insider Monkey
Dec-14-20 10:37AM	Billionaire David Shaw Bets Big on These 3 Healthcare Stocks TipRanks
Dec-11-20 09:30AM	Is Syneos Health (SYNH) a Good Value Investor Stock Now? Zacks
Dec-10-20 08:59AM	Syneos Health Completes Acquisition of Synteract GlobeNewswire
Dec-07-20 05:18PM	Syneos Health to Outline Value Creation Plan at 2020 Analyst and Investor Event GlobeNewswire
08:00AM	VBI Vaccines Selects Syneos Health as Commercialization Partner for Prophylactic 3-Antigen Hepatitis B Vaccine Business Wire
Dec-03-20 08:49AM	Syneos Health and ConcertAI Announce Strategic Collaboration to Accelerate the Use of Real World Evidence and AI to Advance Oncology Research GlobeNewswire
Dec-02-20 08:30AM	Syneos Health Announces Pricing of Secondary Offering of Common Stock GlobeNewswire
Dec-01-20 04:21PM	Syneos Health Announces Secondary Offering of Common Stock GlobeNewswire
Nov-30-20 11:42AM	Here's Why You Should Invest in Syneos Health (SYNH) Now Zacks
Nov-25-20 03:36AM	Estimating The Fair Value Of Syneos Health, Inc. (NASDAQ:SYNH) Simply Wall St.
Nov-24-20 06:07PM	Syneos Health Announces Closing of Offering of $600.0 Million of Senior Notes Due 2029 GlobeNewswire
Nov-18-20 06:52PM	Syneos Health Announces Upsizing and Pricing of Offering of $600.0 Million of Senior Notes Due 2029 GlobeNewswire
07:22AM	Syneos Health Announces Senior Notes Offering GlobeNewswire
Nov-17-20 08:40AM	Syneos Health Names Larry A. Pickett Jr. Chief Information & Digital Officer GlobeNewswire
Nov-16-20 08:43AM	Syneos Health to Host Virtual Analyst and Investor Event on December 8, 2020 GlobeNewswire
Nov-12-20 08:56AM	1Life Healthcare (ONEM) in Focus: Stock Moves 6.3% Higher Zacks
Nov-03-20 08:19AM	Syneos Health (SYNH) Q3 Earnings Top Estimates, Margins Up Zacks
Nov-02-20 05:20PM	Syneos Health to Present at Upcoming Investor Conferences GlobeNewswire +5.40%
10:43AM	Syneos Health, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year Simply Wall St.
Oct-30-20 01:08PM	If You Like EPS Growth Then Check Out Syneos Health (NASDAQ:SYNH) Before It's Too Late Simply Wall St.
Oct-29-20 07:59AM	Syneos Health: Q3 Earnings Insights Benzinga
07:35AM	Syneos Health (SYNH) Tops Q3 Earnings Estimates Zacks
06:13AM	Syneos Health Reports Third Quarter 2020 Results GlobeNewswire
06:00AM	Syneos Health, Inc. to Host Earnings Call ACCESSWIRE
Oct-28-20 05:39PM	Syneos Health to Acquire Synteract, a Top CRO Provider to Emerging Biopharma GlobeNewswire

Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various services spanning Phases I to IV of clinical development, including full service global studies, as well as individual service offerings, such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services comprising deployment solutions; communications solutions, such as public relations, advertising, and medical communications; and consulting services. Its customers include small, mid-sized, and large companies in the pharmaceutical, biotechnology, and medical device industries. Syneos Health, Inc. has a partnership with VBI Vaccines Inc. for the commercialization of 3-antigen prophylactic hepatitis B vaccine in the United States, Europe, and Canada, which is in pending regulatory approvals. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kralowetz Donna Hildebrand	SVP, Chief Accounting Officer	Sep 03	Sale	94.30	248	23,386	6,467	Sep 08 05:18 PM
Meggs Jason M.	Chief Financial Officer	Sep 03	Sale	95.00	9,223	876,185	51,478	Sep 03 05:37 PM
Macdonald Alistair	Chief Executive Officer	Aug 03	Option Exercise	42.76	35,553	1,520,246	231,313	Aug 04 05:24 PM
Macdonald Alistair	Chief Executive Officer	Aug 03	Sale	87.96	35,553	3,127,268	195,760	Aug 04 05:24 PM
Macdonald Alistair	Chief Executive Officer	Aug 02	Sale	89.90	4,710	423,429	195,760	Aug 04 05:24 PM
Monaghan Matthew E.	Director	Jul 16	Sale	88.64	170	15,069	17,138	Jul 19 05:16 PM
Meggs Jason M.	Chief Financial Officer	Jul 06	Option Exercise	45.83	660	30,246	61,321	Jul 07 05:08 PM
Meggs Jason M.	Chief Financial Officer	Jul 06	Sale	90.00	660	59,400	60,701	Jul 07 05:08 PM
Meggs Jason M.	Chief Financial Officer	Jun 30	Option Exercise	43.00	4,668	200,743	63,301	Jul 02 05:04 PM
Meggs Jason M.	Chief Financial Officer	Jun 30	Sale	90.00	4,668	420,120	60,701	Jul 02 05:04 PM
Kralowetz Donna Hildebrand	SVP, Chief Accounting Officer	Jun 18	Sale	85.03	590	50,168	6,467	Jun 21 05:03 PM
Maldonado John L.	Director	Jun 07	Sale	81.20	6,307,489	512,168,107	0	Jun 09 05:55 PM
Allen Tom	Director	Jun 07	Sale	81.20	6,307,489	512,168,107	0	Jun 09 05:51 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Jun 07	Sale	81.20	6,307,489	512,168,107	0	Jun 09 05:40 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Jun 07	Sale	81.20	6,307,489	512,168,107	0	Jun 09 05:41 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Jun 07	Sale	81.20	6,307,489	512,168,107	0	Jun 09 05:40 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Jun 07	Sale	81.20	6,307,489	512,168,107	0	Jun 09 05:38 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Jun 07	Sale	81.20	6,307,489	512,168,107	0	Jun 09 05:39 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Jun 07	Sale	81.20	6,307,489	512,168,107	0	Jun 09 05:38 PM
THOMAS H. LEE ADVISORS, LLC	Director	Jun 07	Sale	81.20	5,043,008	409,492,250	0	Jun 09 05:25 PM
THOMAS H. LEE ADVISORS, LLC	Director	Jun 07	Sale	81.20	1,179	95,735	0	Jun 09 05:25 PM
THOMAS H. LEE ADVISORS, LLC	Director	Jun 07	Sale	81.20	5,043,008	409,492,250	0	Jun 09 05:17 PM
THOMAS H. LEE ADVISORS, LLC	Director	Jun 07	Sale	81.20	1,179	95,735	0	Jun 09 05:17 PM
Macdonald Alistair	Chief Executive Officer	Jun 01	Option Exercise	42.88	4,889	209,640	205,359	Jun 03 05:08 PM
Macdonald Alistair	Chief Executive Officer	Jun 01	Sale	88.20	4,889	431,210	200,470	Jun 03 05:08 PM
Maldonado John L.	Director	May 14	Sale	81.04	448,942	36,382,260	6,307,489	May 18 08:22 PM
Allen Tom	Director	May 14	Sale	81.04	448,942	36,382,260	6,307,489	May 18 08:21 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	May 14	Sale	81.04	448,942	36,382,260	6,307,489	May 18 08:18 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	May 14	Sale	81.04	448,942	36,382,260	6,307,489	May 18 08:16 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	May 14	Sale	81.04	448,942	36,382,260	6,307,489	May 18 08:15 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	May 14	Sale	81.04	448,942	36,382,260	6,307,489	May 18 08:15 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	May 14	Sale	81.04	448,942	36,382,260	6,307,489	May 18 08:13 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	May 14	Sale	81.04	448,942	36,382,260	6,307,489	May 18 08:11 PM
THOMAS H. LEE ADVISORS, LLC	Director	May 12	Sale	81.04	379,789	30,778,101	5,208,835	May 18 09:50 PM
THOMAS H. LEE ADVISORS, LLC	Director	May 12	Sale	81.04	89	7,213	327	May 18 09:50 PM
THOMAS H. LEE ADVISORS, LLC	Director	May 12	Sale	81.04	379,789	30,778,101	5,208,835	May 18 09:49 PM
THOMAS H. LEE ADVISORS, LLC	Director	May 12	Sale	81.04	89	7,213	327	May 18 09:49 PM
THOMAS H. LEE ADVISORS, LLC	Director	May 06	Sale	81.04	3,390,888	274,797,564	5,601,430	May 10 09:30 PM
THOMAS H. LEE ADVISORS, LLC	Director	May 06	Sale	81.04	794	64,346	352	May 10 09:30 PM
THOMAS H. LEE ADVISORS, LLC	Director	May 06	Sale	81.04	3,390,888	274,797,564	5,601,430	May 10 09:27 PM
THOMAS H. LEE ADVISORS, LLC	Director	May 06	Sale	81.04	794	64,346	352	May 10 09:27 PM
Maldonado John L.	Director	May 06	Sale	81.04	4,008,318	324,834,091	6,756,431	May 10 09:53 PM
Allen Tom	Director	May 06	Sale	81.04	4,008,318	324,834,091	6,756,431	May 10 09:53 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	May 06	Sale	81.04	4,008,318	324,834,091	6,756,431	May 10 09:48 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	May 06	Sale	81.04	4,008,318	324,834,091	6,756,431	May 10 09:48 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	May 06	Sale	81.04	4,008,318	324,834,091	6,756,431	May 10 09:48 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	May 06	Sale	81.04	4,008,318	324,834,091	6,756,431	May 10 09:46 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	May 06	Sale	81.04	4,008,318	324,834,091	6,756,431	May 10 09:47 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	May 06	Sale	81.04	4,008,318	324,834,091	6,756,431	May 10 09:46 PM
Meggs Jason M.	Chief Financial Officer	Apr 15	Sale	84.00	6,000	504,000	60,701	Apr 16 05:18 PM
KEEFE MICHELLE	Pres., Commercial Solutions	Apr 15	Sale	82.00	2,736	224,352	43,895	Apr 16 05:16 PM
Macdonald Alistair	Chief Executive Officer	Apr 09	Sale	80.00	14,039	1,123,120	200,470	Apr 12 05:01 PM
Macdonald Alistair	Chief Executive Officer	Apr 01	Option Exercise	40.12	17,398	698,008	231,907	Apr 05 05:00 PM
Macdonald Alistair	Chief Executive Officer	Apr 01	Sale	77.61	17,398	1,350,190	214,509	Apr 05 05:00 PM
Olefson Jonathan	General Counsel & Corp Secty	Mar 29	Sale	77.00	4,000	308,000	24,725	Mar 31 05:08 PM
Harty Linda S	Director	Mar 29	Sale	76.49	7,310	559,142	6,925	Mar 31 05:06 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Mar 03	Sale	74.17	4,654,046	345,213,862	10,764,749	Mar 05 07:12 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Mar 03	Sale	74.17	4,654,046	345,213,862	10,764,749	Mar 05 07:02 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Mar 03	Sale	74.17	4,654,046	345,213,862	10,764,749	Mar 05 06:53 PM
Maldonado John L.	Director	Mar 03	Sale	74.17	4,654,046	345,213,862	10,764,749	Mar 05 07:52 PM
Allen Tom	Director	Mar 03	Sale	74.17	4,654,046	345,213,862	10,764,749	Mar 05 07:44 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Mar 03	Sale	74.17	4,654,046	345,213,862	10,764,749	Mar 05 07:37 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Mar 03	Sale	74.17	4,654,046	345,213,862	10,764,749	Mar 05 07:29 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Mar 03	Sale	74.17	4,654,046	345,213,862	10,764,749	Mar 05 07:22 PM
THOMAS H. LEE ADVISORS, LLC	Director	Mar 03	Sale	74.17	3,995,019	296,330,534	9,106,651	Mar 05 05:00 PM
THOMAS H. LEE ADVISORS, LLC	Director	Mar 03	Sale	74.17	935	69,354	572	Mar 05 05:00 PM
THOMAS H. LEE ADVISORS, LLC	Director	Mar 03	Sale	74.17	3,995,019	296,330,534	9,106,651	Mar 05 05:01 PM
THOMAS H. LEE ADVISORS, LLC	Director	Mar 03	Sale	74.17	935	69,354	572	Mar 05 05:01 PM
Kralowetz Donna Hildebrand	SVP, Chief Accounting Officer	Mar 03	Sale	74.64	248	18,511	5,959	Mar 04 05:23 PM
Macdonald Alistair	Chief Executive Officer	Mar 02	Option Exercise	0.00	36,429	0	231,631	Mar 04 05:44 PM
Kralowetz Donna Hildebrand	SVP, Chief Accounting Officer	Feb 16	Sale	81.00	362	29,322	5,959	Feb 18 05:04 PM
Macdonald Alistair	Chief Executive Officer	Feb 02	Sale	77.11	278	21,438	210,043	Feb 03 05:28 PM
Macdonald Alistair	Chief Executive Officer	Feb 01	Sale	75.71	64,219	4,861,809	210,321	Feb 03 05:28 PM
COLVIN PAUL	Pres., Clinical Solutions	Feb 01	Sale	74.82	8,486	634,923	28,275	Feb 03 05:15 PM
Olefson Jonathan	General Counsel & Corp Secty	Jan 25	Sale	75.68	5,336	403,828	27,214	Jan 27 05:13 PM
KEEFE MICHELLE	Pres., Commercial Solutions	Jan 25	Sale	75.68	4,000	302,720	52,051	Jan 27 05:09 PM
Meggs Jason M.	Chief Financial Officer	Jan 06	Sale	72.00	5,552	399,744	58,951	Jan 07 05:03 PM
Macdonald Alistair	Chief Executive Officer	Dec 23	Sale	70.52	300	21,155	245,187	Dec 28 05:07 PM
Macdonald Alistair	Chief Executive Officer	Dec 22	Sale	70.02	1,200	84,020	245,487	Dec 28 05:07 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 05:27 PM
Allen Tom	Director	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 05:26 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 05:25 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 05:22 PM
Maldonado John L.	Director	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 05:18 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 05:13 PM
THOMAS H. LEE ADVISORS, LLC	Director	Dec 03	Sale	61.28	2,771,132	169,814,969	13,235,545	Dec 07 05:09 PM
THOMAS H. LEE ADVISORS, LLC	Director	Dec 03	Sale	61.28	627	38,423	831	Dec 07 05:09 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 05:07 PM
THOMAS H. LEE ADVISORS, LLC	Director	Dec 03	Sale	61.28	2,771,132	169,814,969	13,235,545	Dec 07 05:05 PM
THOMAS H. LEE ADVISORS, LLC	Director	Dec 03	Sale	61.28	627	38,423	831	Dec 07 05:05 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 04:53 PM
Meggs Jason M.	Chief Financial Officer	Nov 27	Sale	67.00	4,062	272,154	66,003	Nov 30 05:12 PM
Meggs Jason M.	Chief Financial Officer	Nov 24	Sale	67.00	1,938	129,846	70,065	Nov 25 05:01 PM
KEEFE MICHELLE	Pres., Commercial Solutions	Nov 18	Sale	65.00	856	55,640	48,881	Nov 19 05:00 PM
KEEFE MICHELLE	Pres., Commercial Solutions	Nov 17	Sale	62.65	800	50,120	49,643	Nov 19 05:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience